SPINK1 immunostaining was characterized by heterogeneity of the cytoplasmic expression of tumor cells; of the 72 prostate ADK cases analyzed, 61 cases (84.72%) were classified as having a SPINK1 negative status and 11 cases (15.27%) had a SPINK1 positive status. This evidence concerns the gene SPINK1 and neoplasm.